Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 6 November 1998: Vol. 282. no. 5391, pp. 1145 - 1147 DOI: 10.1126/science.282.5391.1145
|
|
Reports
Embryonic Stem Cell Lines Derived from Human Blastocysts
James A. Thomson,
*
Joseph Itskovitz-Eldor,
Sander S. Shapiro,
Michelle A. Waknitz,
Jennifer J. Swiergiel,
Vivienne S. Marshall,
Jeffrey M. Jones
Human blastocyst-derived, pluripotent cell lines are described that
have normal karyotypes, express high levels of telomerase activity, and
express cell surface markers that characterize primate embryonic stem
cells but do not characterize other early lineages. After
undifferentiated proliferation in vitro for 4 to 5 months, these cells
still maintained the developmental potential to form trophoblast and
derivatives of all three embryonic germ layers, including gut
epithelium (endoderm); cartilage, bone, smooth muscle, and striated
muscle (mesoderm); and neural epithelium, embryonic ganglia, and
stratified squamous epithelium (ectoderm). These cell lines should be
useful in human developmental biology, drug discovery, and
transplantation medicine.
J. A. Thomson, M. A. Waknitz, J. J. Swiergiel,
V. S. Marshall, Wisconsin Regional Primate Research Center,
University of Wisconsin, Madison, WI 53715, USA. J. Itskovitz-Eldor, Department of Obstetrics and Gynecology, Rambam
Medical Center, Faculty of Medicine, Technion, Haifa 31096, Israel.
S. S. Shapiro and J. M. Jones, Department of Obstetrics and
Gynecology, University of Wisconsin, Madison, WI 53715, USA.
*
To whom correspondence should be addressed.
Embryonic stem (ES) cells are
derived from totipotent cells of the early mammalian embryo and are
capable of unlimited, undifferentiated proliferation in vitro
(1, 2). In chimeras with intact embryos, mouse ES
cells contribute to a wide range of adult tissues, including germ
cells, providing a powerful approach for introducing specific genetic
changes into the mouse germ line (3). The term "ES cell"
was introduced to distinguish these embryo-derived pluripotent cells
from teratocarcinoma-derived pluripotent embryonal carcinoma (EC) cells
(2). Given the historical introduction of the term "ES
cell" and the properties of mouse ES cells, we proposed that the
essential characteristics of primate ES cells should include (i)
derivation from the preimplantation or periimplantation embryo, (ii)
prolonged undifferentiated proliferation, and (iii) stable
developmental potential to form derivatives of all three embryonic germ
layers even after prolonged culture (4). For ethical and
practical reasons, in many primate species, including humans, the
ability of ES cells to contribute to the germ line in chimeras is not a
testable property. Nonhuman primate ES cell lines provide an accurate
in vitro model for understanding the differentiation of human tissues
(4, 5). We now describe human cell lines that
fulfill our proposed criteria to define primate ES cells.
Fresh or frozen cleavage stage human embryos, produced by in
vitro fertilization (IVF) for clinical purposes, were donated by
individuals after informed consent and after institutional review board
approval. Embryos were cultured to the blastocyst stage, 14 inner cell
masses were isolated, and five ES cell lines originating from five
separate embryos were derived, essentially as described for nonhuman
primate ES cells (5, 6). The resulting
cells had a high ratio of nucleus to cytoplasm, prominent nucleoli, and
a colony morphology similar to that of rhesus monkey ES cells (Fig.
1). Three cell lines (H1, H13, and H14)
had a normal XY karyotype, and two cell lines (H7 and H9) had a normal
XX karyotype. Each of the cell lines was successfully cryopreserved and
thawed. Four of the cell lines were cryopreserved after 5 to 6 months
of continuous undifferentiated proliferation. The other cell line, H9,
retained a normal XX karyotype after 6 months of culture and has now
been passaged continuously for more than 8 months (32 passages). A
period of replicative crisis was not observed for any of the cell
lines.
Fig. 1.
Derivation of the H9 cell
line. (A) Inner cell mass-derived cells attached to mouse
embryonic fibroblast feeder layer after 8 days of culture, 24 hours before first dissociation. Scale bar, 100 µm. (B) H9
colony. Scale bar, 100 µm. (C) H9 cells. Scale bar, 50 µm. (D) Differentiated H9 cells, cultured for 5 days in
the absence of mouse embryonic fibroblasts, but in the presence of
human LIF (20 ng/ml; Sigma). Scale bar, 100 µm.
[View Larger Version of this Image (162K GIF file)]
The human ES cell lines expressed high levels of telomerase activity
(Fig. 2). Telomerase is a
ribonucleoprotein that adds telomere repeats to chromosome ends and is
involved in maintaining telomere length, which plays an important role in replicative life-span (7, 8). Telomerase expression is highly correlated with immortality in human cell lines,
and reintroduction of telomerase activity into some diploid human
somatic cell lines extends replicative life-span (9). Diploid human somatic cells do not express telomerase, have
shortened telomeres with age, and enter replicative senescence after a
finite proliferative life-span in tissue culture
(10-13). In contrast, telomerase is present at
high levels in germ line and embryonic tissues (14). The
high level of telomerase activity expressed by the human ES cell lines
therefore suggests that their replicative life-span will exceed that of
somatic cells.
Fig. 2.
Telomerase expression by human
ES cell lines. MEF, irradiated mouse embryonic fibroblasts used as a
feeder layer for the cells in lanes 4 to 18; 293, adenovirus-transformed kidney epithelial cell line 293; MDA, breast
cancer cell line MDA; TSR8, quantitation control template. Telomerase
activity was measured with the TRAPEZE Telomerase Detection Kit (Oncor,
Gaithersburg, Maryland). The ES cell lines were analyzed at
passages 10 to 13. About 2000 cells were assayed for each telomeric
repeat amplification protocol assay, and 800 cell equivalents were
loaded in each well of a 12.5% nondenaturing polyacrylamide gel.
Reactions were done in triplicate with the third sample of each triplet
heat inactivated for 10 to 15 min at 85°C before reaction to test for
telomerase heat sensitivity (lanes 6, 9, 12, 15, 18, 21, 24, and 27). A
36-base pair internal control for amplification efficiency and
quantitative analysis was run for each reaction as indicated by the
arrowhead. Data were analyzed with the Storm 840 Scanner and ImageQuant
package (Molecular Dynamics). Telomerase activity in the human ES cell
lines ranged from 3.8 to 5.9 times that observed in the immortal human
cell line MDA on a per cell basis.
[View Larger Version of this Image (90K GIF file)]
The human ES cell lines expressed cell surface markers that
characterize undifferentiated nonhuman primate ES and human EC cells,
including stage-specific embryonic antigen (SSEA)-3, SSEA-4, TRA-l-60,
TRA-1-81, and alkaline phosphatase (Fig.
3) (4, 5,
15, 16). The globo-series glycolipid GL7, which
carries the SSEA-4 epitope, is formed by the addition of sialic acid to
the globo-series glycolipid Gb5, which carries the SSEA-3 epitope
(17, 18). Thus, GL7 reacts with antibodies to
both SSEA-3 and SSEA-4 (17, 18). Staining
intensity for SSEA-4 on the human ES cell lines was consistently
strong, but staining intensity for SSEA-3 was weak and varied both
within and among colonies (Fig. 3, D and C). Because GL7 carries both
the SSEA-4 and SSEA-3 epitopes and because staining for SSEA-4 was
consistently strong, the relatively weak staining for SSEA-3 suggests a
restricted access of the antibody to the SSEA-3 epitope. In common with
human EC cells, the undifferentiated human ES cell lines did not stain
for SSEA-1, but differentiated cells stained strongly for SSEA-l
(15) (Fig. 3). Mouse inner cell mass cells, ES cells, and EC
cells express SSEA-1 but do not express SSEA-3 or SSEA-4
(17, 19), suggesting basic species differences
between early mouse and human development.
Fig. 3.
Expression of cell
surface markers by H9 cells. Scale bar, 100 µm. (A)
Alkaline phosphatase. (B) SSEA-1. Undifferentiated
cells failed to stain for SSEA- 1 (large colony, left).
Occasional colonies consisted of nonstained, central,
undifferentiated cells surrounded by a margin of stained,
differentiated, epithelial cells (small colony, right). (C)
SSEA-3. Some small colonies stained uniformly for SSEA-3 (colony left
of center), but most colonies contained a mixture of weakly stained
cells and a majority of nonstained cells (colony right of center).
(D) SSEA-4. (E) TRA-1-60. (F)
TRA-1-81. Similar results were obtained for cell lines H1, H7, H13, and
H14.
[View Larger Version of this Image (161K GIF file)]
The human ES cell lines were derived by the selection and
expansion of individual colonies of a uniform, undifferentiated morphology, but none of the ES cell lines was derived by the clonal expansion of a single cell. The uniform undifferentiated morphology that is shared by human ES and nonhuman primate ES cells and the consistent expression by the human ES cell lines of cell surface markers that uniquely characterize primate ES and human EC cells make
it extremely unlikely that a mixed population of precursor cells was
expanded. However, because the cell lines were not cloned from a single
cell, we cannot rule out the possibility that there is some variation
in developmental potential among the undifferentiated cells, in spite
of their homogeneous appearance.
The human ES cell lines maintained the potential to form
derivatives of all three embryonic germ layers. All five cell lines produced teratomas after injection into severe combined immunodeficient (SCID)-beige mice. Each injected mouse formed a teratoma, and all
teratomas included gut epithelium (endoderm); cartilage, bone, smooth
muscle, and striated muscle (mesoderm); and neural epithelium, embryonic ganglia, and stratified squamous epithelium (ectoderm) (Fig.
4). In vitro, the ES cells differentiated
when cultured in the absence of mouse embryonic fibroblast feeder
layers, both in the presence and absence of human leukemia inhibitory factor (LIF) (Fig. 1). When grown to confluence and allowed to pile up
in the culture dish, the ES cell lines differentiated spontaneously
even in the presence of fibroblasts. After H9 cells were allowed to
differentiate for 2 weeks, both -fetoprotein (350.9 ± 14.2 IU/ml) and human chorionic gonadotropin (hCG, 46.7 ± 5.6 mIU/ml)
were detected in conditioned culture medium, indicating endoderm and
trophoblast differentiation (20).
Fig. 4.
Teratomas formed by the human
ES cell lines in SCID-beige mice. Human ES cells after 4 to 5 months of
culture (passages 14 to 16) from about 50% confluent six-well plates
were injected into the rear leg muscles of 4-week-old male SCID-beige
mice (two or more mice per cell line). Seven to eight weeks after
injection, the resulting teratomas were examined histologically.
(A) Gutlike structures. Cell line H9. Scale bar, 400 µm.
(B) Rosettes of neural epithelium. Cell line H14. Scale bar,
200 µm. (C) Bone. Cell line H14. Scale bar, 100 µm.
(D) Cartilage. Cell line H9. Scale bar, 100 µm.
(E) Striated muscle. Cell line H13. Scale bar, 25 µm.
(F) Tubules interspersed with structures resembling fetal
glomeruli. Cell line H9. Scale bar, 100 µm.
[View Larger Version of this Image (201K GIF file)]
Human ES cells should offer insights into developmental events
that cannot be studied directly in the intact human embryo but that
have important consequences in clinical areas, including birth defects,
infertility, and pregnancy loss. Particularly in the early
postimplantation period, knowledge of normal human development is
largely restricted to the description of a limited number of sectioned
embryos and to analogies drawn from the experimental embryology of
other species (21). Although the mouse is the mainstay
of experimental mammalian embryology, early structures including the
placenta, extraembryonic membranes, and the egg cylinder all differ
substantially from the corresponding structure of the human embryo.
Human ES cells will be particularly valuable for the study of the
development and function of tissues that differ between mice and
humans. Screens based on the in vitro differentiation of human ES cells
to specific lineages could identify gene targets for new drugs, genes
that could be used for tissue regeneration therapies, and teratogenic
or toxic compounds.
Elucidating the mechanisms that control differentiation will
facilitate the efficient, directed differentiation of ES cells to
specific cell types. The standardized production of large, purified
populations of euploid human cells such as cardiomyocytes and neurons
will provide a potentially limitless source of cells for drug discovery
and transplantation therapies. Many diseases, such as
Parkinson's disease and juvenile-onset diabetes mellitus, result from
the death or dysfunction of just one or a few cell types. The
replacement of those cells could offer lifelong treatment. Strategies
to prevent immune rejection of the transplanted cells need to be
developed but could include banking ES cells with defined major
histocompatibility complex backgrounds or genetically manipulating ES
cells to reduce or actively combat immune rejection. Because of the
similarities to humans and human ES cells, rhesus monkeys and rhesus ES
cells provide an accurate model for developing strategies to prevent
immune rejection of transplanted cells and for demonstrating the safety
and efficacy of ES cell-based therapies. Substantial advances in basic
developmental biology are required to direct ES cells efficiently to
lineages of human clinical importance. However, progress has already
been made in the in vitro differentiation of mouse ES cells to
neurons, hematopoietic cells, and cardiac muscle
(22-24). Progress in basic developmental biology
is now extremely rapid; human ES cells will link this progress even
more closely to the prevention and treatment of human disease.
REFERENCES AND NOTES
-
M. Evans and
M. Kaufman,
Nature
292,
154
(1981)
[CrossRef] [Medline]
.
-
G. Martin,
Proc. Natl. Acad. Sci. U.S.A.
78,
7634
(1981)
[Abstract/Free Full Text]
.
-
A. Bradley,
M. Evans,
M. Kaufman,
E. Robertson,
Nature
309,
255
(1984)
[CrossRef] [Medline]
.
-
J. A. Thomson and
V. S. Marshall,
Curr. Top. Dev. Biol.
38,
133
(1998)
[ISI] [Medline]
.
-
J. A. Thomson,
et al.,
Proc. Natl. Acad. Sci. U.S.A.
92,
7844
(1995)
[Abstract/Free Full Text]
.
-
Thirty-six fresh or frozen-thawed donated human embryos
produced by IVF were cultured to the blastocyst stage in G1.2 and G2.2
medium (25). Fourteen of the 20 blastocysts that developed
were selected for ES cell isolation, as described for rhesus monkey ES
cells (5). The inner cell masses were isolated by
immunosurgery (26), with a rabbit antiserum to BeWO cells,
and plated on irradiated (35 grays gamma irradiation) mouse embryonic
fibroblasts. Culture medium consisted of 80% Dulbecco's modified
Eagle's medium (no pyruvate, high glucose formulation; Gibco-BRL)
supplemented with 20% fetal bovine serum (Hyclone), 1 mM glutamine,
0.1 mM
-mercaptoethanol (Sigma), and 1% nonessential amino acid
stock (Gibco-BRL). After 9 to 15 days, inner cell mass-derived
outgrowths were dissociated into clumps either by exposure to
Ca2+/Mg2+-free phosphate-buffered saline with 1 mM EDTA (cell line H1), by exposure to dispase (10 mg/ml; Sigma; cell
line H7), or by mechanical dissociation with a micropipette (cell lines
H9, H13, and H14) and replated on irradiated mouse embryonic
fibroblasts in fresh medium. Individual colonies with a uniform
undifferentiated morphology were individually selected by micropipette,
mechanically dissociated into clumps, and replated. Once established
and expanded, cultures were passaged by exposure to type IV collagenase
(1 mg/ml; Gibco-BRL) or by selection of individual
colonies by micropipette. Clump sizes of about 50 to
100 cells were optimal. Cell lines were initially karyotyped
at passages 2 to 7.
-
C. B. Harley,
Mutat. Res.
256,
271
(1991)
[CrossRef] [ISI] [Medline]
.
-
___,
H. Vaziri,
C. M. Counter,
R. C. Allsopp,
Exp. Gerontol.
27,
375
(1992)
[CrossRef] [ISI] [Medline]
.
-
A. G. Bodnar,
et al.,
Science
279,
349
(1998)
[Abstract/Free Full Text]
.
-
L. Hayflick and
P. S. Moorhead,
Exp. Cell Res.
25,
581
(1961)
.
-
R. C. Allsopp,
et al.,
Proc. Natl. Acad. Sci. U.S.A.
89,
10114
(1992)
[Abstract/Free Full Text]
.
-
C. M. Counter,
et al.,
EMBO J.
11,
1921
(1992)
[ISI] [Medline]
.
-
C. M. Counter,
H. W. Hirte,
S. Bacchetti,
C. B. Harley,
Proc. Natl. Acad. Sci. U.S.A.
91,
2900
(1994)
[Abstract/Free Full Text]
.
-
W. E. Wright,
M. A. Piatyszek,
W. E. Rainey,
W. Byrd,
J. W. Shay,
Dev. Genet.
18,
173
(1996)
[CrossRef] [ISI] [Medline]
.
-
P. W. Andrews, J. Oosterhuis, I. Damjanov, in
Teratocarcinomas and Embryonic Stem Cells: A Practical
Approach, E. Robertson, Ed. (IRL, Oxford, 1987), pp.
207-248.
-
Alkaline phosphatase was detected with Vector Blue
substrate (Vector Labs). SSEA-1, SSEA-3, SSEA-4,
TRA-1-60, and TRA-1-81 were detected by
immunocytochemistry with specific primary monoclonal
antibodies and localized with a biotinylated secondary
antibody and then an avidin or biotinylated
horseradish peroxidase complex (Vectastain ABC system;
Vector Laboratories) as previously described (5).
The ES cell lines were at passages 8 to 12 at the time
markers were analyzed.
-
R. Kannagi,
et al.,
EMBO J.
2,
2355
(1983)
[ISI] [Medline]
.
-
R. Kannagi,
et al.,
J. Biol. Chem.
258,
8934
(1983)
[Abstract/Free Full Text]
.
-
D. Solter and
B. B. Knowles,
Proc. Natl. Acad. Sci. U.S.A.
75,
5565
(1978)
[Abstract/Free Full Text]
.
-
hCG and
-fetoprotein were measured by specific
radioimmunoassay (double AB hCG and AFP-TC kits;
Diagnostic Products, Los Angeles, CA). hCG assays
used the World Health Organization Third
International Standard 75/537. H9 cells were allowed to
grow to confluence (day 0) on plates of irradiated
mouse embryonic fibroblasts. Medium was replaced
daily. After 2 weeks of differentiation, medium in
triplicate wells conditioned for 24 hours was assayed
for hCG and -fetoprotein. No hCG or -fetoprotein
was detected in unconditioned medium.
-
R. O'Rahilly and F. Müller,
Developmental Stages in Human Embryos (Carnegie
Institution of Washington, Washington, DC, 1987).
-
G. Bain,
D. Kitchens,
M. Yao,
J. E. Huettner,
D. I. Gottlieb,
Dev. Biol.
168,
342
(1995)
[CrossRef] [ISI] [Medline]
.
-
M. V. Wiles and
G. Keller,
Development
111,
259
(1991)
[Abstract]
.
-
M. G. Klung,
M. H. Soonpaa,
G. Y. Koh,
L. J. Field,
J. Clin. Invest.
98,
216
(1996)
[ISI] [Medline]
.
-
D. K. Gardner,
et al.,
Fertil. Steril.
69,
84
(1998)
[CrossRef] [ISI] [Medline]
.
-
D. Solter and
B. Knowles,
Proc. Natl. Acad. Sci. U.S.A.
72,
5099
(1975)
[Abstract/Free Full Text]
.
-
We thank the personnel of the IVF clinics at
the University of Wisconsin School of Medicine and at
the Rambam Medical Center for the initial culture and
cryopreservation of the embryos used in this study; D. Gardner
and M. Lane for the G1.2 and G2.2 media; P. Andrews for the
NTERA2 cl.D1 cells and the antibodies used to examine cell
surface markers; C. Harris for karyotype analysis; and
Geron Corporation for the 293 and MDA cell pellets
and for assistance with the telomerase TRAP assay.
Supported by the University of Wisconsin (UIR grant 2060) and
Geron Corporation (grant 133-BU18).
5 August 1998; accepted 7 October 1998
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells.
- C. Unger, S. Gao, M. Cohen, M. Jaconi, R. Bergstrom, F. Holm, A. Galan, E. Sanchez, O. Irion, J. B. Dubuisson, et al. (2009)
Hum. Reprod.
| Abstract »
| Full Text »
| PDF »
- Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease.
- K. D. Boudoulas and A. K. Hatzopoulos (2009)
Dis. Model. Mech.
2, 344-358
| Abstract »
| Full Text »
| PDF »
- Facilitated maturation of Ca2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression.
- J. Liu, D. K. Lieu, C. W. Siu, J.-D. Fu, H.-F. Tse, and R. A. Li (2009)
Am J Physiol Cell Physiol
297, C152-C159
| Abstract »
| Full Text »
| PDF »
- FDA Regulation of Stem Cell-Based Products.
- D. W. Fink Jr. (2009)
Science
324, 1662-1663
| Abstract »
| Full Text »
| PDF »
- Competitive Federalism and the Governance of Controversial Science.
- M. Mintrom (2009)
Publius
| Abstract »
| Full Text »
| PDF »
- Derivation of functional mature neutrophils from human embryonic stem cells.
- Y. Yokoyama, T. Suzuki, M. Sakata-Yanagimoto, K. Kumano, K. Higashi, T. Takato, M. Kurokawa, S. Ogawa, and S. Chiba (2009)
Blood
113, 6584-6592
| Abstract »
| Full Text »
| PDF »
- {beta}4 Tubulin Identifies a Primitive Cell Source for Oligodendrocytes in the Mammalian Brain.
- C. Wu, A. Chang, M. C. Smith, R. Won, X. Yin, S. M. Staugaitis, D. Agamanolis, G. J. Kidd, R. H. Miller, and B. D. Trapp (2009)
J. Neurosci.
29, 7649-7657
| Abstract »
| Full Text »
| PDF »
- Correlation of expression and methylation of imprinted genes with pluripotency of parthenogenetic embryonic stem cells.
- C. Li, Z. Chen, Z. Liu, J. Huang, W. Zhang, L. Zhou, D. L. Keefe, and L. Liu (2009)
Hum. Mol. Genet.
18, 2177-2187
| Abstract »
| Full Text »
| PDF »
- Generation of Pig-Induced Pluripotent Stem Cells with a Drug-Inducible System.
- Z. Wu, J. Chen, J. Ren, L. Bao, J. Liao, C. Cui, L. Rao, H. Li, Y. Gu, H. Dai, et al. (2009)
J Mol Cell Biol
| Abstract »
| Full Text »
| PDF »
- Cellular reprogramming and pluripotency induction.
- M. W. Lensch (2009)
Br. Med. Bull.
90, 19-35
| Abstract »
| Full Text »
| PDF »
- Epithelial Cells Derived from Human Embryonic Stem Cells Display P16INK4A Senescence, Hypermotility, and Differentiation Properties Shared by Many P63+ Somatic Cell Types.
- S. Dabelsteen, P. Hercule, P. Barron, M. Rice, G. Dorsainville, and J. G. Rheinwald (2009)
Stem Cells
27, 1388-1399
| Abstract »
| Full Text »
| PDF »
- A novel embryonic stem cell line derived from the common marmoset monkey (Callithrix jacchus) exhibiting germ cell-like characteristics.
- T. Muller, G. Fleischmann, K. Eildermann, K. Matz-Rensing, P. A. Horn, E. Sasaki, and R. Behr (2009)
Hum. Reprod.
24, 1359-1372
| Abstract »
| Full Text »
| PDF »
- Generation of T Cells from Human Embryonic Stem Cell-Derived Hematopoietic Zones.
- F. Timmermans, I. Velghe, L. Vanwalleghem, M. De Smedt, S. Van Coppernolle, T. Taghon, H. D. Moore, G. Leclercq, A. W. Langerak, T. Kerre, et al. (2009)
J. Immunol.
182, 6879-6888
| Abstract »
| Full Text »
| PDF »
- Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development.
- S. Takei, H. Ichikawa, K. Johkura, A. Mogi, H. No, S. Yoshie, D. Tomotsune, and K. Sasaki (2009)
Am J Physiol Heart Circ Physiol
296, H1793-H1803
| Abstract »
| Full Text »
| PDF »
- mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells.
- J. Zhou, P. Su, L. Wang, J. Chen, M. Zimmermann, O. Genbacev, O. Afonja, M. C. Horne, T. Tanaka, E. Duan, et al. (2009)
PNAS
106, 7840-7845
| Abstract »
| Full Text »
| PDF »
- Skewed X chromosome inactivation in diploid and triploid female human embryonic stem cells.
- W. Liu and X. Sun (2009)
Hum. Reprod.
| Abstract »
| Full Text »
| PDF »
- Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences.
- J. Yu, K. Hu, K. Smuga-Otto, S. Tian, R. Stewart, I. I. Slukvin, and J. A. Thomson (2009)
Science
324, 797-801
| Abstract »
| Full Text »
| PDF »
- Mitochondrial functionality in reproduction: from gonads and gametes to embryos and embryonic stem cells.
- J. Ramalho-Santos, S. Varum, S. Amaral, P. C. Mota, A. P. Sousa, and A. Amaral (2009)
Hum. Reprod. Update
| Abstract »
| Full Text »
| PDF »
- Cell therapies for therapeutic angiogenesis: back to the bench.
- D. P Sieveking and M. K. Ng (2009)
Vascular Medicine
14, 153-166
| Abstract »
| PDF »
- Trophoblast Stem Cells: Models for Investigating Trophectoderm Differentiation and Placental Development.
- G. C. Douglas, C. A. VandeVoort, P. Kumar, T.-C. Chang, and T. G. Golos (2009)
Endocr. Rev.
30, 228-240
| Abstract »
| Full Text »
| PDF »
- Instructing an Embryonic Stem Cell-Derived Oocyte Fate: Lessons from Endogenous Oogenesis.
- C. R. Nicholas, S. L. Chavez, V. L. Baker, and R. A. Reijo Pera (2009)
Endocr. Rev.
30, 264-283
| Abstract »
| Full Text »
| PDF »
- Stem Cells to Pancreatic {beta}-Cells: New Sources for Diabetes Cell Therapy.
- T. Guo and M. Hebrok (2009)
Endocr. Rev.
30, 214-227
| Abstract »
| Full Text »
| PDF »
- Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects.
- B.-Y. Hu, Z.-W. Du, X.-J. Li, M. Ayala, and S.-C. Zhang (2009)
Development
136, 1443-1452
| Abstract »
| Full Text »
| PDF »
- Cre Recombination-Mediated Cassette Exchange for Building Versatile Transgenic Human Embryonic Stem Cells Lines.
- Z.-W. Du, B.-Y. Hu, M. Ayala, B. Sauer, and S.-C. Zhang (2009)
Stem Cells
27, 1032-1041
| Abstract »
| Full Text »
| PDF »
- CD30 Expression Reveals that Culture Adaptation of Human Embryonic Stem Cells Can Occur Through Differing Routes.
- N. J. Harrison, J. Barnes, M. Jones, D. Baker, P. J. Gokhale, and P. W. Andrews (2009)
Stem Cells
27, 1057-1065
| Abstract »
| Full Text »
| PDF »
- Applying a "Double-Feature" Promoter to Identify Cardiomyocytes Differentiated from Human Embryonic Stem Cells Following Transposon-Based Gene Delivery.
- T. I. Orban, A. Apati, A. Nemeth, N. Varga, V. Krizsik, A. Schamberger, K. Szebenyi, Z. Erdei, G. Varady, E. Karaszi, et al. (2009)
Stem Cells
27, 1077-1087
| Abstract »
| Full Text »
| PDF »
- Signaling Hierarchy Regulating Human Endothelial Cell Development.
- M. A. Kelly and K. K. Hirschi (2009)
Arterioscler. Thromb. Vasc. Biol.
29, 718-724
| Abstract »
| Full Text »
| PDF »
- Development of cloned embryos from porcine neural stem cells and amniotic fluid-derived stem cells transfected with enhanced green fluorescence protein gene.
- Y.-M. Zheng, H.-Y. Zhao, X.-E Zhao, F.-S. Quan, S. Hua, X.-Y. He, J. Liu, X.-N. He, and H. Lin (2009)
Reproduction
137, 793-801
| Abstract »
| Full Text »
| PDF »
- Species-Specific In vivo Engraftment of the Human BL Melanoma Cell Line Results in an Invasive Dedifferentiated Phenotype Not Present in Xenografts.
- J. Cedervall, S. Jamil, L. Prasmickaite, Y. Cheng, M. Eskandarpour, J. Hansson, G. M. Maelandsmo, U. Ringborg, M. Gulyas, H. S. Zhen, et al. (2009)
Cancer Res.
69, 3746-3754
| Abstract »
| Full Text »
| PDF »
- Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos.
- J.L. Cortes, L. Sanchez, G. Ligero, I. Gutierrez-Aranda, P. Catalina, C. Elosua, P.E. Leone, R. Montes, C. Bueno, V. Ramos-Mejia, et al. (2009)
Hum. Reprod.
| Abstract »
| Full Text »
| PDF »
- Neuropilin-1 Identifies Endothelial Precursors in Human and Murine Embryonic Stem Cells Before CD34 Expression.
- T. Cimato, J. Beers, S. Ding, M. Ma, J. P. McCoy, M. Boehm, and E. G. Nabel (2009)
Circulation
119, 2170-2178
| Abstract »
| Full Text »
| PDF »
- Stem Cells as Tools in Regenerative Therapy for Retinal Degeneration.
- V. Enzmann, E. Yolcu, H. J. Kaplan, and S. T. Ildstad (2009)
Arch Ophthalmol
127, 563-571
| Abstract »
| Full Text »
| PDF »
- Directed Differentiation of Pluripotent Stem Cells: From Developmental Biology to Therapeutic Applications.
- S. Irion, M.C. Nostro, S.J. Kattman, and G.M. Keller (2009)
Cold Spring Harb Symp Quant Biol
| Abstract »
| PDF »
- A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration.
- P. Koch, T. Opitz, J. A. Steinbeck, J. Ladewig, and O. Brustle (2009)
PNAS
106, 3225-3230
| Abstract »
| Full Text »
| PDF »
- An Enhanced Mass Spectrometry Approach Reveals Human Embryonic Stem Cell Growth Factors in Culture.
- S. C. Bendall, C. Hughes, J. L. Campbell, M. H. Stewart, P. Pittock, S. Liu, E. Bonneil, P. Thibault, M. Bhatia, and G. A. Lajoie (2009)
Mol. Cell. Proteomics
8, 421-432
| Abstract »
| Full Text »
| PDF »
- ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells.
- X. Li, R. Krawetz, S. Liu, G. Meng, and D. E. Rancourt (2009)
Hum. Reprod.
24, 580-589
| Abstract »
| Full Text »
| PDF »
- REVIEW PAPER: Cancer Stem Cells and Cancer Nonstem Cells: From Adult Stem Cells or from Reprogramming of Differentiated Somatic Cells.
- J. E. Trosko (2009)
Vet. Pathol.
46, 176-193
| Abstract »
| Full Text »
| PDF »
- Integrated Chemical Genomics Reveals Modifiers of Survival in Human Embryonic Stem Cells.
- R. Damoiseaux, S. P. Sherman, J. A. Alva, C. Peterson, and A. D. Pyle (2009)
Stem Cells
27, 533-542
| Abstract »
| Full Text »
| PDF »
- Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells.
- J. Zhang, G. F. Wilson, A. G. Soerens, C. H. Koonce, J. Yu, S. P. Palecek, J. A. Thomson, and T. J. Kamp (2009)
Circ. Res.
104, e30-e41
| Abstract »
| Full Text »
| PDF »
- Epigenetic reprogramming and induced pluripotency.
- K. Hochedlinger and K. Plath (2009)
Development
136, 509-523
| Abstract »
| Full Text »
| PDF »
- Human ESC-derived Neural Rosettes and Neural Stem Cell Progression.
- Y. Elkabetz and L. Studer (2009)
Cold Spring Harb Symp Quant Biol
| Abstract »
| PDF »
- Regulation of Pluripotency and Reprogramming by Transcription Factors.
- D. Pei (2009)
J. Biol. Chem.
284, 3365-3369
| Abstract »
| Full Text »
| PDF »
- Reviews: Stem Cells and Female Reproduction.
- Hongling Du and H. S. Taylor (2009)
Reproductive Sciences
16, 126-139
| Abstract »
| PDF »
- Brief Report--Human Embryonic Stem Cell-Derived Mesenchymal Progenitors Possess Strong Immunosuppressive Effects Toward Natural Killer Cells as Well as T Lymphocytes.
- B. L. Yen, C. J. Chang, K.-J. Liu, Y. C. Chen, H.-I Hu, C.-H. Bai, and M.-L. Yen (2009)
Stem Cells
27, 451-456
| Abstract »
| Full Text »
| PDF »
- Derivation and Characterization of Canine Embryonic Stem Cell Lines with In Vitro and In Vivo Differentiation Potential.
- A. K. Vaags, S. Rosic-Kablar, C. J. Gartley, Y. Z. Zheng, A. Chesney, D. A.F. Villagomez, S. A. Kruth, and M. R. Hough (2009)
Stem Cells
27, 329-340
| Abstract »
| Full Text »
| PDF »
- Genetic Analysis of the Role of the Reprogramming Gene LIN-28 in Human Embryonic Stem Cells.
- H. Darr and N. Benvenisty (2009)
Stem Cells
27, 352-362
| Abstract »
| Full Text »
| PDF »
- Markers that define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos.
- G. Cauffman, M. De Rycke, K. Sermon, I. Liebaers, and H. Van de Velde (2009)
Hum. Reprod.
24, 63-70
| Abstract »
| Full Text »
| PDF »
- A Feeder-Free and Efficient Production of Functional Neutrophils from Human Embryonic Stem Cells.
- K. Saeki, K. Saeki, M. Nakahara, S. Matsuyama, N. Nakamura, Y. Yogiashi, A. Yoneda, M. Koyanagi, Y. Kondo, and A. Yuo (2009)
Stem Cells
27, 59-67
| Abstract »
| Full Text »
| PDF »
- A Novel Approach for the Derivation of Putative Primordial Germ Cells and Sertoli Cells from Human Embryonic Stem Cells.
- N. Bucay, M. Yebra, V. Cirulli, I. Afrikanova, T. Kaido, A. Hayek, and A. M.P. Montgomery (2009)
Stem Cells
27, 68-77
| Abstract »
| Full Text »
| PDF »
- Human Embryonic Stem Cell Differentiation Toward Regional Specific Neural Precursors.
- S. Erceg, M. Ronaghi, and M. Stojkovic (2009)
Stem Cells
27, 78-87
| Abstract »
| Full Text »
| PDF »
- Isolation and Characterization of Pluripotent Human Spermatogonial Stem Cell-Derived Cells.
- N. Kossack, J. Meneses, S. Shefi, H. N. Nguyen, S. Chavez, C. Nicholas, J. Gromoll, P. J. Turek, and R. A. Reijo-Pera (2009)
Stem Cells
27, 138-149
| Abstract »
| Full Text »
| PDF »
- In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells.
- N. S. Hwang, S. Varghese, H. J. Lee, Z. Zhang, Z. Ye, J. Bae, L. Cheng, and J. Elisseeff (2008)
PNAS
105, 20641-20646
| Abstract »
| Full Text »
| PDF »
- Dissecting Signaling Pathways That Govern Self-renewal of Rabbit Embryonic Stem Cells.
- S. Wang, Y. Shen, X. Yuan, K. Chen, X. Guo, Y. Chen, Y. Niu, J. Li, R.-H. Xu, X. Yan, et al. (2008)
J. Biol. Chem.
283, 35929-35940
| Abstract »
| Full Text »
| PDF »
- Esrrb Activates Oct4 Transcription and Sustains Self-renewal and Pluripotency in Embryonic Stem Cells.
- X. Zhang, J. Zhang, T. Wang, M. A. Esteban, and D. Pei (2008)
J. Biol. Chem.
283, 35825-35833
| Abstract »
| Full Text »
| PDF »
- The ethics of stem cell research: can the disagreements be resolved?.
- J. H. Solbakk and S. Holm (2008)
J. Med. Ethics
34, 831-832
| Full Text »
| PDF »
- What happened to the stem cells?.
- T Hviid Nielsen (2008)
J. Med. Ethics
34, 852-857
| Abstract »
| Full Text »
| PDF »
- Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor.
- R. Martin-Ibanez, C. Unger, A. Stromberg, D. Baker, J.M. Canals, and O. Hovatta (2008)
Hum. Reprod.
23, 2744-2754
| Abstract »
| Full Text »
| PDF »
- OCT4 Spliced Variants Are Differentially Expressed in Human Pluripotent and Nonpluripotent Cells.
- Y. Atlasi, S. J. Mowla, S. A.M. Ziaee, P. J. Gokhale, and P. W. Andrews (2008)
Stem Cells
26, 3068-3074
| Abstract »
| Full Text »
| PDF »
- Secreted Proteoglycans Directly Mediate Human Embryonic Stem Cell-Basic Fibroblast Growth Factor 2 Interactions Critical for Proliferation.
- M. E. Levenstein, W. T. Berggren, J. E. Lee, K. R. Conard, R. A. Llanas, R. J. Wagner, L. M. Smith, and J. A. Thomson (2008)
Stem Cells
26, 3099-3107
| Abstract »
| Full Text »
| PDF »
- Mouse Meningiocytes Express Sox2 and Yield High Efficiency of Chimeras after Nuclear Reprogramming with Exogenous Factors.
- D. Qin, Y. Gan, K. Shao, H. Wang, W. Li, T. Wang, W. He, J. Xu, Y. Zhang, Z. Kou, et al. (2008)
J. Biol. Chem.
283, 33730-33735
| Abstract »
| Full Text »
| PDF »
- Generation of Cardiomyocytes from New Human Embryonic Stem Cell Lines Derived from Poor-quality Blastocysts.
- A. Raya, I. Rodriguez-Piza, B. Aran, A. Consiglio, P.N. Barri, A. Veiga, and J.C. Izpisua Belmonte (2008)
Cold Spring Harb Symp Quant Biol
| Abstract »
| PDF »
- Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells.
- H. Reinecke, E. Minami, W.-Z. Zhu, and M. A. Laflamme (2008)
Circ. Res.
103, 1058-1071
| Abstract »
| Full Text »
| PDF »
- Ronin and Caspases in Embryonic Stem Cells: A New Perspective on Regulation of the Pluripotent State.
- T.P. Zwaka (2008)
Cold Spring Harb Symp Quant Biol
| Abstract »
| PDF »
- On Women, Egg Cells and Embryos: Gender in the Regulatory Debates on Embryonic Research in the Netherlands.
- M. Kirejczyk (2008)
European Journal of Women's Studies
15, 377-391
| Abstract »
| PDF »
- Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges.
- S. Ziebe, P. Devroey, and on behalf of the State of the ART 2007 Workshop Gr (2008)
Hum. Reprod. Update
14, 583-592
| Abstract »
| Full Text »
| PDF »
- Chemically defined sequential culture media for TH+ cell derivation from human embryonic stem cells.
- T. Song, G. Chen, Y. Wang, G. Mao, Y. Wang, and H. Bai (2008)
Mol. Hum. Reprod.
14, 619-625
| Abstract »
| Full Text »
| PDF »
- Rho-associated kinase inhibitor Y-27632 promotes survival of cynomolgus monkey embryonic stem cells.
- T. Takehara, T. Teramura, Y. Onodera, R. Kakegawa, N. Fukunaga, M. Takenoshita, N. Sagawa, K. Fukuda, and Y. Hosoi (2008)
Mol. Hum. Reprod.
14, 627-634
| Abstract »
| Full Text »
| PDF »
- Feeder-Free Monolayer Cultures of Human Embryonic Stem Cells Express an Epithelial Plasma Membrane Protein Profile.
- D. Van Hoof, S. R. Braam, W. Dormeyer, D. Ward-van Oostwaard, A. J.R. Heck, J. Krijgsveld, and C. L. Mummery (2008)
Stem Cells
26, 2777-2781
| Abstract »
| Full Text »
| PDF »
- Enrichment and Differentiation of Human Germ-Like Cells Mediated by Feeder Cells and Basic Fibroblast Growth Factor Signaling.
- F. D. West, D. W. Machacek, N. L. Boyd, K. Pandiyan, K. R. Robbins, and S. L. Stice (2008)
Stem Cells
26, 2768-2776
| Abstract »
| Full Text »
| PDF »
- Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells.
- E. T. Zambidis, T. Soon Park, W. Yu, A. Tam, M. Levine, X. Yuan, M. Pryzhkova, and B. Peault (2008)
Blood
112, 3601-3614
| Abstract »
| Full Text »
| PDF »
- Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state.
- S.-L. Lin, D. C. Chang, S. Chang-Lin, C.-H. Lin, D. T.S. Wu, D. T. Chen, and S.-Y. Ying (2008)
RNA
14, 2115-2124
| Abstract »
| Full Text »
| PDF »
- Expression profiles of protein tyrosine kinase genes in human embryonic stem cells.
- M.-Y. Son, J. Kim, H.-W. Han, S.-M. Woo, Y. S. Cho, Y.-K. Kang, and Y.-M. Han (2008)
Reproduction
136, 423-432
| Abstract »
| Full Text »
| PDF »
- Similar biological characteristics of human embryonic stem cell lines with normal and abnormal karyotypes.
- X. Sun, X. Long, Y. Yin, Y. Jiang, X. Chen, W. Liu, W. Zhang, H. Du, S. Li, Y. Zheng, et al. (2008)
Hum. Reprod.
23, 2185-2193
| Abstract »
| Full Text »
| PDF »
- Glycan stem-cell markers are specifically expressed by spermatogonia in the adult non-human primate testis.
- T. Muller, K. Eildermann, R. Dhir, S. Schlatt, and R. Behr (2008)
Hum. Reprod.
23, 2292-2298
| Abstract »
| Full Text »
| PDF »
- Lentiviral-Mediated HoxB4 Expression in Human Embryonic Stem Cells Initiates Early Hematopoiesis in a Dose-Dependent Manner but Does Not Promote Myeloid Differentiation.
- C. Unger, E. Karner, A. Treschow, B. Stellan, U. Felldin, H. Concha, M. Wendel, O. Hovatta, A. Aints, L. Ahrlund-Richter, et al. (2008)
Stem Cells
26, 2455-2466
| Abstract »
| Full Text »
| PDF »
- OP9 Stroma Augments Survival of Hematopoietic Precursors and Progenitors During Hematopoietic Differentiation from Human Embryonic Stem Cells.
- J. Ji, K. Vijayaragavan, M. Bosse, K. Weisel, and M. Bhatia (2008)
Stem Cells
26, 2485-2495
| Abstract »
| Full Text »
| PDF »
- CD34+ Testicular Stromal Cells Support Long-Term Expansion of Embryonic and Adult Stem and Progenitor Cells.
- J. Kim, M. Seandel, I. Falciatori, D. Wen, and S. Rafii (2008)
Stem Cells
26, 2516-2522
| Abstract »
| Full Text »
| PDF »
- Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells.
- C. H. Martin, P. S. Woll, Z. Ni, J. C. Zuniga-Pflucker, and D. S. Kaufman (2008)
Blood
112, 2730-2737
| Abstract »
| Full Text »
| PDF »
- Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors.
- K. Suzuki, K. Mitsui, E. Aizawa, K. Hasegawa, E. Kawase, T. Yamagishi, Y. Shimizu, H. Suemori, N. Nakatsuji, and K. Mitani (2008)
PNAS
105, 13781-13786
| Abstract »
| Full Text »
| PDF »
- Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium.
- M. K. Furue, J. Na, J. P. Jackson, T. Okamoto, M. Jones, D. Baker, R.-I. Hata, H. D. Moore, J. D. Sato, and P. W. Andrews (2008)
PNAS
105, 13409-13414
| Abstract »
| Full Text »
| PDF »
- Combinatorial Signals of Activin/Nodal and Bone Morphogenic Protein Regulate the Early Lineage Segregation of Human Embryonic Stem Cells.
- Z. Wu, W. Zhang, G. Chen, L. Cheng, J. Liao, N. Jia, Y. Gao, H. Dai, J. Yuan, L. Cheng, et al. (2008)
J. Biol. Chem.
283, 24991-25002
| Abstract »
| Full Text »
| PDF »
- Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.
- R.-J. Swijnenburg, S. Schrepfer, J. A. Govaert, F. Cao, K. Ransohoff, A. Y. Sheikh, M. Haddad, A. J. Connolly, M. M. Davis, R. C. Robbins, et al. (2008)
PNAS
105, 12991-12996
| Abstract »
| Full Text »
| PDF »
- Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis.
- F. Ma, Y. Ebihara, K. Umeda, H. Sakai, S. Hanada, H. Zhang, Y. Zaike, E. Tsuchida, T. Nakahata, H. Nakauchi, et al. (2008)
PNAS
105, 13087-13092
| Abstract »
| Full Text »
| PDF »
- Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells Express the Serotonin Receptor and Are Susceptible to JC Virus Infection.
- C. Schaumburg, B. A. O'Hara, T. E. Lane, and W. J. Atwood (2008)
J. Virol.
82, 8896-8899
| Abstract »
| Full Text »
| PDF »
- Prevention of Amino Acid Conversion in SILAC Experiments with Embryonic Stem Cells.
- S. C. Bendall, C. Hughes, M. H. Stewart, B. Doble, M. Bhatia, and G. A. Lajoie (2008)
Mol. Cell. Proteomics
7, 1587-1597
| Abstract »
| Full Text »
| PDF »
- In Search of the In Vivo Identity of Mesenchymal Stem Cells.
- L. da Silva Meirelles, A. I. Caplan, and N. B. Nardi (2008)
Stem Cells
26, 2287-2299
| Abstract »
| Full Text »
| PDF »
- Control of Human Embryonic Stem Cell Colony and Aggregate Size Heterogeneity Influences Differentiation Trajectories.
- C. L. Bauwens, R. Peerani, S. Niebruegge, K. A. Woodhouse, E. Kumacheva, M. Husain, and P. W. Zandstra (2008)
Stem Cells
26, 2300-2310
| Abstract »
| Full Text »
| PDF »
- Recombinant Vitronectin Is a Functionally Defined Substrate That Supports Human Embryonic Stem Cell Self-Renewal via {alpha}V{beta}5 Integrin.
- S. R. Braam, L. Zeinstra, S. Litjens, D. Ward-van Oostwaard, S. van den Brink, L. van Laake, F. Lebrin, P. Kats, R. Hochstenbach, R. Passier, et al. (2008)
Stem Cells
26, 2257-2265
| Abstract »
| Full Text »
| PDF »
- Stem Cell-Derived Therapeutic Myelin Repair Requires 7% Cell Replacement.
- M. E. Kiel, C. P. Chen, D. Sadowski, and R. D. McKinnon (2008)
Stem Cells
26, 2229-2236
| Abstract »
| Full Text »
| PDF »
- Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons.
- J. T. Dimos, K. T. Rodolfa, K. K. Niakan, L. M. Weisenthal, H. Mitsumoto, W. Chung, G. F. Croft, G. Saphier, R. Leibel, R. Goland, et al. (2008)
Science
321, 1218-1221
| Abstract »
| Full Text »
| PDF »
- Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling.
- D. C. Hay, J. Fletcher, C. Payne, J. D. Terrace, R. C. J. Gallagher, J. Snoeys, J. R. Black, D. Wojtacha, K. Samuel, Z. Hannoun, et al. (2008)
PNAS
105, 12301-12306
| Abstract »
| Full Text »
| PDF »
|
|